Physician profile
Myron L Rolle
NPI 1053841296
$289,729.37
in general payments reported to CMS, 2019-2025
9 companies · $169K in 2025
The $169K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.65 · 2020: $10K · 2021: $36K · 2022: $74K · 2024: $30.39 · 2025: $169K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $164K · Travel and Lodging: $4,150 · Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $163,750.00 |
| Travel and Lodging | $4,150.39 |
| Food and Beverage | $837.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $167,715.09 | 2025 | |
| Abiomed | $120,958.38 | 2020-2022 | |
| Globus Medical, INC. | $309.16 | 2025 | Creo, Excelsius Gps |
| Medtronic, INC. | $176.87 | 2025 | Stealthstation S8 Platform |
| Livanova USA, INC. | $156.90 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Aesculap, INC. | $141.54 | 2025 | M.Blue |
| Monteris Medical Corporation | $139.95 | 2025 | Neuroblate |
| Zimmer Biomet Holdings, INC. | $98.83 | 2025 | Rosa |
| Medtronic USA, INC. | $32.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$727,908.38 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Rolle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.